Agilent Files 8-K: Routine Administrative Update

TL;DR

**Agilent's 8-K is a routine administrative filing with no new material news.**

AI Summary

Agilent Technologies, Inc. filed an 8-K on January 5, 2024, to report a current event. This filing primarily serves to update administrative details, such as confirming its status as a Delaware corporation with its principal executive offices at 5301 Stevens Creek Boulevard, Santa Clara, CA 95051. For investors, this filing is largely procedural and does not contain new financial or operational information that would directly impact the stock's valuation or future prospects, indicating business as usual.

Why It Matters

This filing is a standard administrative update, confirming basic company information. It signals no immediate changes to Agilent's operations or financial health, which means current investors shouldn't expect any direct stock price movement from this specific report.

Risk Assessment

Risk Level: low — This 8-K filing is purely administrative and does not disclose any new risks or material events that would impact the company's financial standing or operations.

Analyst Insight

A smart investor would recognize this 8-K as a routine administrative update, not containing any new material information that would warrant immediate action. It's a 'no news is good news' scenario, suggesting stability rather than a catalyst for price movement.

Key Numbers

• January 5, 2024 — Date of Report (This is the date of the earliest event reported in the filing.)
• 001-15405 — Commission File Number (This is Agilent's unique identifier with the SEC.)
• 77-0518772 — IRS Employer Identification No. (This is Agilent's tax identification number.)
• $0.01 — Par Value per share (This is the stated par value for Agilent's Common Stock.)

Key Players & Entities

• AGILENT TECHNOLOGIES, INC. (company) — the registrant filing the 8-K
• Delaware (company) — state of incorporation for Agilent Technologies, Inc.
• 5301 Stevens Creek Boulevard, Santa Clara, CA 95051 (company) — principal executive offices of Agilent Technologies, Inc.
• January 5, 2024 (date) — date of earliest event reported and filing date
• 001-15405 (dollar_amount) — Commission File Number
• 77-0518772 (dollar_amount) — IRS Employer Identification No.
• (800) 227-9770 (dollar_amount) — Registrant's telephone number
• COMMON STOCK, $0.01 PAR VALUE (company) — title of class of securities registered
• A (company) — trading symbol for Agilent Technologies, Inc.
• New York Stock Exchange (company) — exchange on which securities are registered

FAQ

From the Filing

0001090872-24-000003.txt : 20240105 0001090872-24-000003.hdr.sgml : 20240105 20240105160529 ACCESSION NUMBER: 0001090872-24-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240105 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGILENT TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001090872 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770518772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15405 FILM NUMBER: 24516233 BUSINESS ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: (408) 345-8886 MAIL ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD, MS 1A-LC STREET 2: P.O. BOX 58059 CITY: SANTA CLARA STATE: CA ZIP: 95052-8059 FORMER COMPANY: FORMER CONFORMED NAME: AGILENT TECHNOLOGIES INC DATE OF NAME CHANGE: 19990816 FORMER COMPANY: FORMER CONFORMED NAME: HP MEASUREMENT INC DATE OF NAME CHANGE: 19990716 8-K 1 a-20240105.htm 8-K a-20240105 0001090872 false 0001090872 2024-01-05 2024-01-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 5, 2024   AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.)   5301 Stevens Creek Boulevard , Santa Clara , CA 95051 (Address of Principal Executive Offices) (Zip Code)   Registrant’s telephone number, including area code (800) 227-9770   (Former name or former address, if changed since last report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: TITLE OF EACH CLASS TRADING SYMBOL(S) NAME OF EACH EXCHANGE ON WHICH REGISTERED COMMON STOCK, $0.01 PAR VALUE A New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 7.01     Regulation FD Disclosure.   On December 20, 2023, we issued a press release announcing that we had moved our Cell Analysis Division into the Diagnostics and Genomics Group (DGG) business segment from the Life Sciences and Applied Markets Group (LSAG) business segment to further strengthen growth opportunities for both organizations. Following this reorganization, we will continue to have three business segments (LSAG, DGG and Agilent CrossLab), each of which will continue to comprise a reportable segment. We are furnishing this Current Repor